norethindrone acetate has been researched along with Cancer of Endometrium in 6 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both treatments were generally well tolerated, with most adverse events (>90%) being mild to moderate, although minor differences in the tolerability profile were observed between treatments." | 2.72 | Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study. ( Arguinzoniz, M; Boschitsch, E; Concin, H; De Geyter, C; Ehrenborg, A; Heikkinen, J; Hobson, R; Ibarra de Palacios, P; Samsioe, G; Scheurer, C; Schmidt, G, 2006) |
| " Women who developed this tumor on sequential therapy in general received less than the recommended guidelines for daily dosage and monthly duration of progestin." | 1.29 | Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy. ( Barbuto, DA; Judd, HL; Karlan, BY; Lagasse, LD; Leuchter, RS; McGonigle, KF, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simsek, T | 1 |
| Karakus, C | 1 |
| Trak, B | 1 |
| Oehler, MK | 1 |
| MacKenzie, IZ | 1 |
| Wallwiener, D | 1 |
| Bicknell, R | 1 |
| Rees, MC | 1 |
| Maia, H | 1 |
| Maltez, A | 1 |
| Studard, E | 1 |
| Athayde, C | 1 |
| Coutinho, EM | 1 |
| Samsioe, G | 1 |
| Boschitsch, E | 1 |
| Concin, H | 1 |
| De Geyter, C | 1 |
| Ehrenborg, A | 1 |
| Heikkinen, J | 1 |
| Hobson, R | 1 |
| Arguinzoniz, M | 1 |
| Ibarra de Palacios, P | 1 |
| Scheurer, C | 1 |
| Schmidt, G | 1 |
| McGonigle, KF | 1 |
| Karlan, BY | 1 |
| Barbuto, DA | 1 |
| Leuchter, RS | 1 |
| Lagasse, LD | 1 |
| Judd, HL | 1 |
| Gruber, DM | 1 |
| Wagner, G | 1 |
| Kurz, C | 1 |
| Sator, MO | 1 |
| Huber, JC | 1 |
2 trials available for norethindrone acetate and Cancer of Endometrium
| Article | Year |
|---|---|
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; | 2002 |
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Therapy, Combination; Endometrial | 2006 |
4 other studies available for norethindrone acetate and Cancer of Endometrium
| Article | Year |
|---|---|
Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia.
Topics: Cells, Cultured; Endometrial Neoplasms; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expre | 2002 |
Effect of previous hormone replacement therapy on endometrial polyps during menopause.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Case-Control Studies; Endometrial Neoplasms; | 2004 |
Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
Topics: Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endome | 1994 |
Endometrial cancer after combined hormone replacement therapy.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estradiol; Female; Hormone Replacement Therapy; Humans; Middl | 1999 |